USP45 Represses Melanoma Development by Deubiquitinating and Stabilizing Tumor Suppressor MRGPRF
Advanced Science · 2025
DOI: 10.1002/advs.202503106 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Wancong Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic Surgery and Burn Center, Second Affiliated Hospital, Shantou University Medical College, Shantou, Guangdong, 515051, China. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, Ubiquitin-Specific Proteases, Tumor Suppressor Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation, 2020 Li Ka Shing Foundation Cross-Disciplinary Research Grant.
Abstract (Originalsprache)
Melanoma, a highly malignant skin cancer, has seen a rising incidence and death toll. MRGPRF is a novel melanoma suppressor that inhibits the PI3K/AKT pathway. However, the regulation of MRGPRF in melanoma remains unclear. Here, 40 ubiquitin‐specific proteases (USPs) are screened and USP45 is identified as a significant stabilizer of MRGPRF. Immunohistochemistry on melanoma patient biopsies demonstrates that USP45 expression is markedly reduced in melanoma tissues compared to adjacent noncancerous epidermis. Bioinformatic analyses corroborate that USP45 mRNA levels are downregulated in melanoma, and low USP45 expression is associated with poor patient prognosis. Functional assays demonstrate that USP45 overexpression inhibits melanoma cell malignancy, whereas USP45 knockdown promotes it. Mechanistically, USP45's catalytic domain directly binds to the N‐terminal of MRGPRF and stabilizes MRGPRF, likely by removing its K63‐linked ubiquitination in melanoma cells. The antimelanoma effects of USP45 are mitigated by MRGPRF depletion, while MRGPRF overexpression rescues the enhanced malignant phenotype induced by USP45 deficiency. In vivo, a melanoma xenograft mouse model shows that USP45 overexpression significantly impairs melanoma progression. These findings establish USP45 as a melanoma suppressor, at least partially through its stabilization of MRGPRF, highlighting a novel mechanism in melanoma pathogenesis and suggesting that USP45 agonists may serve as potential therapeutic agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Plastic Surgery and Burn Center, Second Affiliated Hospital, Shantou University Medical College, Shantou, Guangdong, 515051, China.
- Plastic Surgery Institute of Shantou University Medical College, Shantou, Guangdong, 515051, China.
- Shantou Plastic Surgery Clinical Research Center, Shantou, Guangdong, 515051, China.
- Research Center of Translational Medicine, Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, 515051, China.
- College of Medicine, Shantou University, Shantou, Guangdong, 515051, China.
- Department of Plastic and Reconstructive Surgery, Central South University Third Xiangya Hospital, Changsha, Hunan, 410000, China.
ORCID-Profile: Shijie Tang
Förderung
- National Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research Foundation
- 2020 Li Ka Shing Foundation Cross-Disciplinary Research Grant
- Guangdong University Innovation Team Project
- Provincial science and technology innovation strategy special project funding program
- 2022 Shantou University Graduated Student Innovation Program
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Zhang, W., Chen, L., Zhao, J., Ma, A., Shi, W., Zhang, Y., Tang, Z., Guo, J., Xu, Z., Zhou, J., & Tang, S. (2025). USP45 Represses Melanoma Development by Deubiquitinating and Stabilizing Tumor Suppressor MRGPRF. Advanced Science. https://doi.org/10.1002/advs.202503106
Vancouver
Zhang W, Chen L, Zhao J, Ma A, Shi W, Zhang Y, et al. USP45 Represses Melanoma Development by Deubiquitinating and Stabilizing Tumor Suppressor MRGPRF. Advanced Science. 2025. doi:10.1002/advs.202503106
BibTeX
@article{Zhang2025,
author = {Zhang, Wancong and Chen, Liyun and Zhao, Jing and Ma, Aiwei and Shi, Wenqi and Zhang, Yiwen and Tang, Zixuan and Guo, Jiarui and Xu, Zaihua and Zhou, Jianda and Tang, Shijie},
title = {USP45 Represses Melanoma Development by Deubiquitinating and Stabilizing Tumor Suppressor MRGPRF},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202503106}
}
EUVIMED